Evidence Synthesis
Cerebraint Sees Gross Margin Accelerate to 46.85% / -2915.08%, Down from Previous Quarter.
The company's revenue growth slowed to .7% / .3267971%. Daily volume decreased to . The close price dropped to .05 INR.
Evidence Synthesis
Last synthesized: 23 Jul 2026, 02:23
Evidence Synthesis
Cerebraint Sees Gross Margin Accelerate to 46.85% / -2915.08%, Down from Previous Quarter.
The company's revenue growth slowed to .7% / .3267971%. Daily volume decreased to . The close price dropped to .05 INR.
Source observations behind the synthesis narrative.
| Metric | Value | Trend | |
|---|---|---|---|
| GROSS_MARGIN | 46.85 % | -2,915.08 | ▲ |
| MARGINAL_OPERATING_LEVERAGE | -2,915.08 % | 0 | ▼ |
| REVENUE_GROWTH_YOY | -54.7 % | — | - |
| PRICE_CHANGE_PERCENT | -0.327 % | — | - |
| DAILY_VOLUME | 71,966 shares | 1,37,629 | ▼ |
| CLOSE_PRICE | 3.05 INR | 3.06 | ▼ |